Human Serum Albumin and Affibody Fusion Proteins for Targeted Drug Delivery to HER2 Positive Cells
<p> Human epidermal growth factor receptor 2 (HER2) is a well-studied therapeutic target as well as a biomarker of breast cancer. HER2-targeting affibody (Z<sub> HER2:342</sub>) is a novel small scaffold protein with an extreme high affinity against HER2 screened by phage display....
| Main Author: | |
|---|---|
| Language: | EN |
| Published: |
University of the Sciences in Philadelphia
2017
|
| Subjects: | |
| Online Access: | http://pqdtopen.proquest.com/#viewpdf?dispub=10629208 |